It's not the current product lineups that matter the most for big pharma companies. It's their pipelines.
Three big pharma companies boasting the strongest pipelines are Johnson & Johnson (NYSE: JNJ), Novartis (NYSE: NVS), and Roche (NASDAQOTH: RHHBY). Here's what sets these drugmakers apart from their peers.